Blood Borne Virus Review for Healthcare Professionals
Blood Borne Virus Review for Healthcare Professionals
Response-guided therapy leads to complete cure after three weeks of all-oral triple-direct acting antiviral regimens in non-cirrhotic chronic hepatitis C genotype 1b Chinese subjects (SODAPI study)
The diagnosis of HCV infection has high cost and is time consuming for clinical laboratories.The addition of HCV antigen testing to the battery of laboratory HCV tests and the application of a cost efficient testing algorithm warrants further consideration.
View by Category
Twitter Updates
From Twitter Web App
BBV Review
@DrLoomba @JVLazarus There are more advanced ML & AI methods including LIVERFASt a product of Fibronostics which ha… https://t.co/hTlk8Bilc2
Monday, 15 February 2021 10:54
From Twitter Web App
BBV Review
RT @HenryEChang: HCV treatment in 2020: How to translate highly effective
therapies into elimination strategies→https://t.co/gvgyBRaitj vi…
Friday, 04 September 2020 11:46
From Twitter Web Client
BBV Review
RT @HenryEChang: Sustainable Development Goals for HBV elimination in South Africa: challenges, progress & the road ahead→https://t.co/TCu…
Wednesday, 22 May 2019 09:04
From Twitter Web Client
BBV Review
RT @grahamscooke: Two helpful pieces on HCV reinfection from @GregDore2 @ProfJohnDillon at a time when we're trying to get access to retrea…
Sunday, 05 May 2019 13:34